Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Venglustat. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UGCG known ✓ | Q16739 | 1/20 | 0.83 |
| ▸ | NTMT1 | Q9BV86 | 20/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Venglustat SCHEMBL29358474 | 1.00 | NTMT1 (0.83) | NTMT1UGCG | |
| Venglustat SCHEMBL12615333 | 0.91 | NTMT1 (1.00) | NTMT1UGCG | |
| Venglustat SCHEMBL29359568 | 0.91 | NTMT1 (1.00) | NTMT1UGCG | |
| Venglustat SCHEMBL12615329 | 0.91 | NTMT1 (1.00) | NTMT1UGCG | |
| Venglustat SCHEMBL19844439 | 0.91 | NTMT1 (1.00) | NTMT1UGCG | |
| SCHEMBL19407265 | 0.84 | NTMT1 (1.00) | NTMT1UGCG | |
| SCHEMBL18309554 | 0.83 | NTMT1 (1.00) | NTMT1UGCG | |
| Malic Acid SCHEMBL23234120 | 0.81 | NTMT1 (0.50) | NTMT1UGCG | |
| Malic Acid SCHEMBL17504472 | 0.80 | NTMT1 (0.52) | NTMT1UGCG | |
| Malic Acid SCHEMBL17504470 | 0.80 | NTMT1 (0.52) | NTMT1UGCG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4559918-A2 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | Genzyme Corporation (US) | 2025-05-28 | — | — | EP | disclosed |
| EP-3673906-B1 | GLUCOSYLCERAMIDE SYNTHASE INHIBITORS | GENZYME CORP (US) | 2025-05-14 | — | — | EP | disclosed |